• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝移植治疗甲基丙二酸血症即刻期的营养管理和生化结局

Nutritional Management and Biochemical Outcomes during the Immediate Phase after Liver Transplant for Methylmalonic Acidemia.

机构信息

Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

出版信息

Nutrients. 2020 Sep 29;12(10):2976. doi: 10.3390/nu12102976.

DOI:10.3390/nu12102976
PMID:33003354
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7599551/
Abstract

Methylmalonic acidemia (MMA) is caused by a deficiency of methyl-malonyl-CoA mutase. It is a multisystemic condition with poor clinical outcomes characterized by frequent metabolic decompensation with acidosis, hyperammonemia and encephalopathy. Restriction of intact protein and supplementation with amino acid-based formula play an important role in its management. Recently, liver transplant (LT) became a treatment option for MMA patients. However, there has been no current consensus on the post-operative nutrition management for MMA patients undergoing transplant, particularly during the initial phase of recovery period with catabolic stressors. We performed a retrospective analysis of clinical and nutritional management as well as biochemical profiles before and after LT in five patients with MMA. Through this study, we observed significant improvement of MMA-associated metabolites after LT. MMA patients were able to tolerate increased intact protein intake post-operatively. At least 1-1.5 g/kg/day of total protein during the acute phase after transplant may be tolerated without worsening of the metabolite levels. This information provides a guide in how to nutritionally manage MMA after LT.

摘要

甲基丙二酸血症(MMA)是由甲基丙二酰辅酶 A 变位酶缺乏引起的。它是一种多系统疾病,临床结局较差,特征为频繁发生代谢失代偿,伴有酸中毒、高血氨和脑病。限制完整蛋白并补充基于氨基酸的配方在其治疗中发挥重要作用。最近,肝移植(LT)已成为 MMA 患者的治疗选择。然而,对于接受移植的 MMA 患者,特别是在伴有分解代谢应激的恢复期初始阶段,尚无术后营养管理的共识。我们对五例 MMA 患者的 LT 前后的临床和营养管理以及生化特征进行了回顾性分析。通过这项研究,我们观察到 MMA 患者在 LT 后 MMA 相关代谢物明显改善。MMA 患者在术后能够耐受增加的完整蛋白摄入。在移植后急性期,至少 1-1.5 g/kg/天的总蛋白可能耐受而不会使代谢物水平恶化。这些信息为 LT 后 MMA 的营养管理提供了指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c029/7599551/b00c1cc42dfd/nutrients-12-02976-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c029/7599551/9305ae170445/nutrients-12-02976-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c029/7599551/b00c1cc42dfd/nutrients-12-02976-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c029/7599551/9305ae170445/nutrients-12-02976-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c029/7599551/b00c1cc42dfd/nutrients-12-02976-g002.jpg

相似文献

1
Nutritional Management and Biochemical Outcomes during the Immediate Phase after Liver Transplant for Methylmalonic Acidemia.肝移植治疗甲基丙二酸血症即刻期的营养管理和生化结局
Nutrients. 2020 Sep 29;12(10):2976. doi: 10.3390/nu12102976.
2
Liver transplantation in propionic and methylmalonic acidemia: A single center study with literature review.肝移植治疗丙酸血症和甲基丙二酸血症:单中心研究并文献复习
Mol Genet Metab. 2019 Dec;128(4):431-443. doi: 10.1016/j.ymgme.2019.11.001. Epub 2019 Nov 7.
3
Stabilization of blood methylmalonic acid level in methylmalonic acidemia after liver transplantation.肝移植后甲基丙二酸血症患者血液中甲基丙二酸水平的稳定情况。
Pediatr Transplant. 2010 May;14(3):337-41. doi: 10.1111/j.1399-3046.2009.01227.x. Epub 2009 Aug 14.
4
Long-term clinical outcomes and health-related quality of life in patients with isolated methylmalonic acidemia after liver transplantation: experience from the largest cohort study in China.孤立性甲基丙二酸血症患者肝移植后的长期临床结局和健康相关生活质量:来自中国最大队列研究的经验。
World J Pediatr. 2024 Aug;20(8):809-821. doi: 10.1007/s12519-023-00780-0. Epub 2024 Jan 8.
5
Liver Transplantation for Propionic Acidemia and Methylmalonic Acidemia: Perioperative Management and Clinical Outcomes.肝移植治疗丙酸血症和甲基丙二酸血症:围手术期管理和临床结局。
Liver Transpl. 2018 Sep;24(9):1260-1270. doi: 10.1002/lt.25304.
6
Methylmalonic acidemia/propionic acidemia - the biochemical presentation and comparing the outcome between liver transplantation versus non-liver transplantation groups.甲基丙二酸血症/丙酸血症-肝移植与非肝移植组的生化表现和结局比较。
Orphanet J Rare Dis. 2019 Apr 2;14(1):73. doi: 10.1186/s13023-019-1045-1.
7
Early Liver Transplantation for Neonatal-Onset Methylmalonic Acidemia.新生儿期起病的甲基丙二酸血症的早期肝移植
Pediatrics. 2015 Jul;136(1):e252-6. doi: 10.1542/peds.2015-0175. Epub 2015 Jun 15.
8
Metabolic phenotype of methylmalonic acidemia in mice and humans: the role of skeletal muscle.小鼠和人类甲基丙二酸血症的代谢表型:骨骼肌的作用。
BMC Med Genet. 2007 Oct 15;8:64. doi: 10.1186/1471-2350-8-64.
9
Renal transplantation in 4 patients with methylmalonic aciduria: a cell therapy for metabolic disease.4 例甲基丙二酸血症患者的肾移植:代谢性疾病的细胞治疗。
Mol Genet Metab. 2013 Sep-Oct;110(1-2):106-10. doi: 10.1016/j.ymgme.2013.05.001. Epub 2013 May 14.
10
Perioperative management of living-donor liver transplantation for methylmalonic acidemia.甲基丙二酸血症活体肝移植的围手术期管理
Paediatr Anaesth. 2016 Jul;26(7):694-702. doi: 10.1111/pan.12930. Epub 2016 May 24.

引用本文的文献

1
The Efficacy and Outcomes of Renal Replacement Therapy in Pediatric Metabolic Disorders.小儿代谢紊乱中肾脏替代治疗的疗效与结果
J Clin Med. 2024 Oct 28;13(21):6452. doi: 10.3390/jcm13216452.
2
Non-Hodgkin lymphoma in a kidney transplanted patient with methylmalonic acidemia: Metabolic susceptibility and the role of immunosuppression.一名患有甲基丙二酸血症的肾移植患者发生非霍奇金淋巴瘤:代谢易感性及免疫抑制的作用
JIMD Rep. 2024 Jan 10;65(2):56-62. doi: 10.1002/jmd2.12411. eCollection 2024 Mar.
3
Biomarkers to predict disease progression and therapeutic response in isolated methylmalonic acidemia.

本文引用的文献

1
Post-transplantation Outcomes in Patients with PA or MMA: A Review of the Literature.移植后 PA 或 MMA 患者的预后:文献综述。
Adv Ther. 2020 May;37(5):1866-1896. doi: 10.1007/s12325-020-01305-1. Epub 2020 Apr 8.
2
Liver transplantation in propionic and methylmalonic acidemia: A single center study with literature review.肝移植治疗丙酸血症和甲基丙二酸血症:单中心研究并文献复习
Mol Genet Metab. 2019 Dec;128(4):431-443. doi: 10.1016/j.ymgme.2019.11.001. Epub 2019 Nov 7.
3
Perioperative characteristics and management of liver transplantation for isolated methylmalonic acidemia-the largest experience in China.
预测孤立性甲基丙二酸血症疾病进展和治疗反应的生物标志物。
J Inherit Metab Dis. 2023 Jul;46(4):554-572. doi: 10.1002/jimd.12636. Epub 2023 Jun 6.
孤立性甲基丙二酸血症肝移植的围手术期特征与管理——中国最大规模经验
Hepatobiliary Surg Nutr. 2019 Oct;8(5):470-479. doi: 10.21037/hbsn.2019.03.04.
4
Pathophysiology of propionic and methylmalonic acidemias. Part 1: Complications.丙酸血症和甲基丙二酸血症的病理生理学。第 1 部分:并发症。
J Inherit Metab Dis. 2019 Sep;42(5):730-744. doi: 10.1002/jimd.12129. Epub 2019 Aug 7.
5
Kidney disease and organ transplantation in methylmalonic acidaemia.甲基丙二酸血症中的肾脏疾病与器官移植
Pediatr Transplant. 2019 Jun;23(4):e13407. doi: 10.1111/petr.13407. Epub 2019 Apr 11.
6
Liver Transplantation for Propionic Acidemia and Methylmalonic Acidemia: Perioperative Management and Clinical Outcomes.肝移植治疗丙酸血症和甲基丙二酸血症:围手术期管理和临床结局。
Liver Transpl. 2018 Sep;24(9):1260-1270. doi: 10.1002/lt.25304.
7
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Pediatric Critically Ill Patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition.儿童危重症患者营养支持治疗提供和评估指南:重症医学学会和肠外与肠内营养学会。
JPEN J Parenter Enteral Nutr. 2017 Jul;41(5):706-742. doi: 10.1177/0148607117711387. Epub 2017 Jun 2.
8
Methylmalonic and propionic acidemias: clinical management update.甲基丙二酸血症和丙酸血症:临床管理更新
Curr Opin Pediatr. 2016 Dec;28(6):682-693. doi: 10.1097/MOP.0000000000000422.
9
Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management.小儿遗传性代谢疾病的肝移植:适应证、并发症及围手术期管理的考量
Pediatr Transplant. 2016 Sep;20(6):756-69. doi: 10.1111/petr.12741. Epub 2016 Jun 21.
10
Liver transplantation in severe methylmalonic acidemia: The sooner, the better.严重甲基丙二酸血症的肝移植:越早越好。
J Pediatr. 2015 Nov;167(5):1173. doi: 10.1016/j.jpeds.2015.08.022. Epub 2015 Sep 9.